These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8913498

  • 41. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
    Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS.
    Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.
    Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC.
    Biochem J; 1996 Apr 01; 315 ( Pt 1)(Pt 1):335-42. PubMed ID: 8670128
    [Abstract] [Full Text] [Related]

  • 44. Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor.
    Gohda E, Matsunaga T, Kataoka H, Takebe T, Yamamoto I.
    Cytokine; 1994 Nov 01; 6(6):633-40. PubMed ID: 7534491
    [Abstract] [Full Text] [Related]

  • 45. Contrasting effects of the protein kinase C inhibitor, staurosporine, on cytokine and phorbol ester stimulation of fructose 2,6-bisphosphate and prostaglandin E production by fibroblasts in vitro. Comparative studies using interleukin-1 alpha, tumour necrosis factor alpha, transforming growth factor beta, interferon-gamma and 12-O-tetradecanoylphorbol 13-acetate.
    Taylor DJ, Evanson JM, Woolley DE.
    Biochem J; 1990 Aug 01; 269(3):573-7. PubMed ID: 2117917
    [Abstract] [Full Text] [Related]

  • 46. Phorbol ester or epidermal growth factor (EGF) stimulates the concurrent accumulation of mRNA for the EGF receptor and its ligand transforming growth factor-alpha in a breast cancer cell line.
    Bjorge JD, Paterson AJ, Kudlow JE.
    J Biol Chem; 1989 Mar 05; 264(7):4021-7. PubMed ID: 2521857
    [Abstract] [Full Text] [Related]

  • 47. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C.
    Domeij H, Modéer T, Yucel-Lindberg T.
    J Periodontal Res; 2004 Oct 05; 39(5):308-14. PubMed ID: 15324351
    [Abstract] [Full Text] [Related]

  • 48. Interleukin-1beta enhanced action of kinins on extracellular matrix of spontaneous hypertensive rat cardiac fibroblasts.
    Imai C, Okamura A, Peng JF, Kitamura Y, Printz MP.
    Clin Exp Hypertens; 2005 Jan 05; 27(1):59-69. PubMed ID: 15773230
    [Abstract] [Full Text] [Related]

  • 49. Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries.
    Mann JS, Kindy MS, Edwards DR, Curry TE.
    Endocrinology; 1991 Apr 05; 128(4):1825-32. PubMed ID: 1848503
    [Abstract] [Full Text] [Related]

  • 50. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells.
    Pang IH, Hellberg PE, Fleenor DL, Jacobson N, Clark AF.
    Invest Ophthalmol Vis Sci; 2003 Aug 05; 44(8):3485-93. PubMed ID: 12882798
    [Abstract] [Full Text] [Related]

  • 51. Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells.
    Alitalo R, Partanen J, Pertovaara L, Hölttä E, Sistonen L, Andersson L, Alitalo K.
    Blood; 1990 May 15; 75(10):1974-82. PubMed ID: 2159816
    [Abstract] [Full Text] [Related]

  • 52. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.
    Hanemaaijer R, Koolwijk P, le Clercq L, de Vree WJ, van Hinsbergh VW.
    Biochem J; 1993 Dec 15; 296 ( Pt 3)(Pt 3):803-9. PubMed ID: 8280080
    [Abstract] [Full Text] [Related]

  • 53. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha.
    Lefebvre V, Peeters-Joris C, Vaes G.
    Biochim Biophys Acta; 1991 Aug 13; 1094(1):8-18. PubMed ID: 1653026
    [Abstract] [Full Text] [Related]

  • 54. Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts.
    DiBattista JA, Pelletier JP, Zafarullah M, Fujimoto N, Obata K, Martel-Pelletier J.
    J Rheumatol Suppl; 1995 Feb 13; 43():123-8. PubMed ID: 7752115
    [Abstract] [Full Text] [Related]

  • 55. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D.
    Am J Pathol; 1997 Feb 13; 150(2):653-66. PubMed ID: 9033278
    [Abstract] [Full Text] [Related]

  • 56. The effects of epidermal growth factor and transforming growth factor-α on secretion of interleukin-8 and growth-regulated oncogene-α in human granulosa-lutein cells.
    Kawano Y, Zeineh K, Furukawa Y, Utsunomiya Y, Okamoto M, Narahara H.
    Gynecol Obstet Invest; 2012 Feb 13; 73(3):189-94. PubMed ID: 22414682
    [Abstract] [Full Text] [Related]

  • 57. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts.
    Lin N, Sato T, Ito A.
    Arthritis Rheum; 2001 Sep 13; 44(9):2193-200. PubMed ID: 11592385
    [Abstract] [Full Text] [Related]

  • 58. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K, Tsutsumi M, Kido A, Sakitani H, Takahama M, Yoshimoto M, Motoyama M, Tatsumi K, Tsunoda T, Konishi Y.
    Carcinogenesis; 1999 Jul 13; 20(7):1323-9. PubMed ID: 10383907
    [Abstract] [Full Text] [Related]

  • 59. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 60. Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.
    Ree AH, Maelandsmo GM, Fodstad O.
    Clin Exp Metastasis; 1996 Sep 15; 14(4):381-8. PubMed ID: 8878412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.